In this study, stimulation of prostate cancer cells with apelin abolished TIMP2 expression by a greater extent than TIMP1 or TIMP3, suggesting that TIMP2 is more important than other TIMPs in apelin-mediated motility of prostate cancer cells. The gene discussed is APLN; the disease is prostate carcinoma.